*Company applications are now closed.
If you have any questions, please contact Jack Lee.*
Canadian health science companies will have the opportunity to pitch in person to global investors at the 2024 OBIO® Investment Summit (OIS) in Toronto on February 14-16, 2024.
Health science companies commercializing products and services in therapeutics, medical devices, diagnostics, digital health and health IT have the opportunity to pitch to global investors. An exclusive, invite-only event, the Summit provides a private environment for one-to-one meetings and relationship building with venture capital, strategic partners and investors specializing in health science.
The Summit will highlight Canada’s most promising early-stage and venture-backed companies across a full spectrum of technologies: therapeutics, medical devices, diagnostics, digital health and health IT. Companies chosen to present at the OIS have collectively raised $1.6 B and licensed out $2B since 2018.
Companies need to demonstrate high growth potential and readiness for investment by venture investors. Selected companies will be required to pay the conference fee to present to investors and strategic partners, and can setup one-on-one meetings at the event.
Presentation review is available for companies selected to present.
Company eligibility requirements:
Has operations in Canada.
Focuses on developing human life science products, including but not limited to, therapeutics, medical devices, diagnostics, digital health and health IT.
Expects to be actively fundraising and partnering with investors in 2024.